Dexlansoprazole
Showing 1 - 25 of 213
Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)
Recruiting
- Healthy
- Bioequivalence Study
- Dexlansoprazole
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Bariatric Surgery Trial (dexlansoprazole serum concentration, upper endoscopy)
Withdrawn
- Bariatric Surgery
- dexlansoprazole serum concentration
- upper endoscopy
- (no location specified)
Jan 17, 2022
Gastro Esophageal Reflux Trial in Chicago (dexlansoprazole)
Enrolling by invitation
- Gastro Esophageal Reflux
- dexlansoprazole
-
Chicago, IllinoisNorthwestern Memorial Health Care
Dec 7, 2021
Erosive Esophagitis Trial in Worldwide (Dexlansoprazole)
Not yet recruiting
- Erosive Esophagitis
- Dexlansoprazole
-
Mobile, Alabama
- +44 more
Jun 13, 2022
Hypothyroidism;Postablative Trial in United States (levothyroxine sodium capsule, Proton pump inhibitor (PPI), Levothyroxine
Completed
- Hypothyroidism;Postablative
- levothyroxine sodium capsule
- +2 more
-
La Jolla, California
- +8 more
Apr 1, 2022
Helicobacter Pylori Infection Trial in Kaohsiung ((dexlan+amox+clar+metr)+(dexlan+amox), dexlan+clarith+amox+metro)
Completed
- Helicobacter Pylori Infection
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Nov 1, 2020
Healthy Volunteers Trial in Tempe (30 mg dexlansoprazole capsules manufactured at TOB, 30 mg dexlansoprazole capsules
Completed
- Healthy Volunteers
- 30 mg dexlansoprazole capsules manufactured at TOB
- +3 more
-
Tempe, ArizonaCelerion
Mar 17, 2020
H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity
Not yet recruiting
- COVID-19
- No intervention (Retrospective Cohort Observational)
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 6, 2021
Dexlansoprazole Modified Release in Gastroesophageal Reflux
Withdrawn
- Gastroesophageal Reflux Disease
- (no location specified)
Apr 13, 2020
Laryngopharyngeal Reflux Trial in Indianapolis (dexlansoprazole, Placebo)
Terminated
- Laryngopharyngeal Reflux
- dexlansoprazole
- Placebo
-
Indianapolis, IndianaClarian North Hospital -- IUMG Clinic
Sep 6, 2019
Pediatric Gastroesophageal Reflux Disease Trial in Worldwide (Dexlansoprazole)
Withdrawn
- Pediatric Gastroesophageal Reflux Disease
- Dexlansoprazole
-
Los Angeles, California
- +21 more
Apr 13, 2020
Healthy Volunteers Trial in Salt Lake City (30 mg dexlansoprazole capsules manufactured at TOB, 30 mg dexlansoprazole capsules
Completed
- Healthy Volunteers
- 30 mg dexlansoprazole capsules manufactured at TOB
- +3 more
-
Salt Lake City, UtahPRAHS Phase 1 unit
Mar 15, 2019
Non Cardiac Chest Pain Trial in Kubang Kerian (Empirical therapy group, Guided therapy group)
Completed
- Non Cardiac Chest Pain
- Empirical therapy group
- Guided therapy group
-
Kubang Kerian, Kelantan, MalaysiaHospitial Universiti Sains Malaysia
Aug 22, 2019
Helicobacter Pylori Infection Trial in Kaohsiung (Dexlan, Amoxicillin, Clarithromycin 500mg)
Completed
- Helicobacter Pylori Infection
- Dexlan
- +3 more
-
Kaohsiung, TaiwanKaohsiung Chang Gung Memorial Hospital,Taiwan
May 11, 2019
Healthy Volunteers Trial in Beijing (Dexlansoprazole)
Completed
- Healthy Volunteers
- Dexlansoprazole
-
Beijing, Beijing, ChinaPhase I Clinical Trial Department
Feb 8, 2019
Patients on Treatment With Systemic Steroids Trial in Seoul (Lansoprazole, Fexuprazan Hydrochloride)
Not yet recruiting
- Patients on Treatment With Systemic Steroids
- Lansoprazole
- Fexuprazan Hydrochloride
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 6, 2023
Helicobacter Pylori Infection Trial in Seoul (Tegoprazan 50 mg Triple Therapy, Tegoprazan 100 mg Triple Therapy, Lansoprazole
Recruiting
- Helicobacter Pylori Infection
- Tegoprazan 50 mg Triple Therapy
- +2 more
-
Seoul, Korea, Republic ofChung-Ang University Hosptial
Jul 3, 2023
Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)
Not yet recruiting
- Gastro Esophageal Reflux
- Lansoprazole 15 mg
- Lansoprazole 15mg/Calcium carbonate 600mg
- (no location specified)
Sep 3, 2023
Heartburn, Gastroesophageal Reflux Disease Trial in China (Dexlansoprazole, Placebo)
Completed
- Heartburn
- Gastroesophageal Reflux Disease
- Dexlansoprazole
- Placebo
-
Beijing, Beijing, China
- +24 more
Jul 3, 2019
Helicobacter Pylori Infection Trial in New Taipei City (Vonoprazan and Amoxicillin, Lansoprazole, Amoxicillin, Clarithromycin
Recruiting
- Helicobacter Pylori Infection
- Vonoprazan and Amoxicillin
- Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
-
New Taipei City, TaiwanFu Jen Catholic University Hospital, Fu Jen Catholic University
Dec 3, 2023
Gastric Ulcer Trial (JP-1366 20mg, Lansoprazole 30mg)
Not yet recruiting
- Gastric Ulcer
- JP-1366 20mg
- Lansoprazole 30mg
- (no location specified)
Jul 1, 2022
Erosive Reflux Disease Trial in Iksan (Tegoprazan 50mg QD, Lansoprazole 30mg QD)
Completed
- Erosive Reflux Disease
- Tegoprazan 50mg QD
- Lansoprazole 30mg QD
-
Iksan, Muwang-ro 895, Korea, Republic ofWonkwang University Hospital
Jul 28, 2022
Erosive Esophagitis Trial in China (Dexlansoprazole, Lansoprazole, Placebo)
Terminated
- Erosive Esophagitis
- Dexlansoprazole
- +2 more
-
Beijing, Beijing, China
- +24 more
Oct 11, 2018
Helicobacter Pylori Infection Trial in Incheon (Tegoprazan, Lansoprazole)
Active, not recruiting
- Helicobacter Pylori Infection
-
Incheon, Korea, Republic ofIncheon St. Mary's Hospital
Jan 27, 2022